Ciltacabtagene autoleucel, an anti–B-cell maturation antigen chimeric antigen receptor T-cell therapy, for relapsed/refractory multiple myeloma: CARTITUDE-1 2-year follow-up Journal Article
| Authors: | Martin, T.; Usmani, S. Z.; Berdeja, J. G.; Agha, M.; Cohen, A. D.; Hari, P.; Avigan, D.; Deol, A.; Htut, M.; Lesokhin, A.; Munshi, N. C.; O'Donnell, E.; Stewart, A. K.; Schecter, J. M.; Goldberg, J. D.; Jackson, C. C.; Yeh, T. M.; Banerjee, A.; Allred, A.; Zudaire, E.; Deraedt, W.; Olyslager, Y.; Zhou, C.; Pacaud, L.; Madduri, D.; Jakubowiak, A.; Lin, Y.; Jagannath, S. |
| Article Title: | Ciltacabtagene autoleucel, an anti–B-cell maturation antigen chimeric antigen receptor T-cell therapy, for relapsed/refractory multiple myeloma: CARTITUDE-1 2-year follow-up |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 6 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-02-20 |
| Start Page: | 1265 |
| End Page: | 1274 |
| Language: | English |
| DOI: | 10.1200/jco.22.00842 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| PMCID: | PMC9937098 |
| PUBMED: | 35658469 |
| DOI/URL: | |
| Notes: | Accession Number: 161906937 -- Entry Date: In Process -- Revision Date: 20230217 -- Publication Type: Article -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 8309333. -- Source: Cinahl |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work